title: Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring?
authors.affiliation: Department of Clinical Chemistry, University Medical Center Goettingen, Goettingen, Germany. gunnar.brandhorst@med.uni-goettingen.de
authors.forename: Gunnar
authors.initials: G
authors.lastname: Brandhorst
authors.forename: Michael
authors.initials: M
authors.lastname: Oellerich
authors.forename: Gregory
authors.initials: G
authors.lastname: Maine
authors.forename: Paul
authors.initials: P
authors.lastname: Taylor
authors.forename: Gerhard
authors.initials: G
authors.lastname: Veen
authors.forename: Pierre
authors.initials: P
authors.lastname: Wallemacq
mesh_terms: D001322:Autoanalysis; D002853:Chromatography, Liquid / Q000191:economics / Q000379:methods* / Q000639:trends; D016903:Drug Monitoring / Q000191:economics / Q000379:methods* / Q000639:trends; D006801:Humans; D007118:Immunoassay / Q000191:economics / Q000379:methods* / Q000639:trends; D012680:Sensitivity and Specificity; D053719:Tandem Mass Spectrometry / Q000191:economics / Q000379:methods* / Q000639:trends